Kristen Gil Buys Shares of UnitedHealth Group

Kristen Gil, an insider at UnitedHealth Group Incorporated, purchased 8 shares of the company on June 23, 2026. The transaction was not conducted under a pre-planned 10b5-1 trading plan. On the same day, shares of UnitedHealth Group traded near $405.8 on the NYSE.

What Changed in Kristen Gil's UnitedHealth Group Position

Kristen Gil's recent purchase adds to her holdings in UnitedHealth Group. Although the transaction involved a small number of shares, it is part of a broader pattern of insider activity within the company.

Other Institutional Activity in UnitedHealth Group

Several major institutional investors have also been active in UnitedHealth Group. BlackRock, Inc. reduced its holdings by 1,276,021 shares, now holding 73,467,531 shares valued at about $19.88 billion, marking a 1.7% decrease. Vanguard Capital Management LLC opened a new position with 58,870,777 shares, valued at approximately $15.93 billion. State Street Corp increased its stake slightly by 100,016 shares, totaling 45,332,186 shares worth $12.27 billion, a 0.2% increase. Capital World Investors grew its position by 5,192,373 shares, now holding 27,783,415 shares valued at $7.52 billion, reflecting a 23% increase.

UnitedHealth Group Incorporated Stock Up 3.3%

Shares of NYSE:UNH traded near $405.8 on Friday. UnitedHealth Group has a market capitalization of $369.3 billion and a P/E ratio of 30.6. The stock's 52-week range is between $234.6 and $415.98. It has a 50-day moving average of $372.67 and a 200-day moving average of $333.55. The company's beta is 0.65, indicating lower volatility compared to the market.

Recent Earnings

UnitedHealth Group reported revenue of $449.71 billion, with a modest growth rate of 2%. The company's earnings per share (EPS) stands at $13.27, with a net margin of 2.68% and a return on equity (ROE) of 12.18%. The next earnings release is scheduled for July 16, 2026.

Dividend

UnitedHealth Group pays an annual dividend of $9.28, yielding 2.31% with a payout ratio of 66.57%. The company continues to provide a steady income for its shareholders.

Insider Buying and Selling at UnitedHealth Group Incorporated

In addition to Kristen Gil's purchase, several other insiders bought shares on June 23, 2026. Frederick William McNabb III acquired 50 shares, Paul Garcia and Charles Baker each purchased 13 shares, and Christopher Zaetta, EVP & Chief Legal Officer, bought 61 shares. CEO Stephen Hemsley also acquired 46 shares. These transactions were not part of any pre-planned trading programs.

Analysts Set New Price Targets

Analysts have been bullish on UnitedHealth Group. On June 24, 2026, B of A Securities maintained a 'buy' rating with a price target of $475. Leerink Partners also reaffirmed a 'buy' rating with a target of $462 on June 17, 2026. JP Morgan and Mizuho kept their 'buy' ratings with targets of $466 and $460, respectively, on June 8, 2026. The consensus among 26 analysts is a 'buy' rating, with a mean price target of $409.77.

About UnitedHealth Group

UnitedHealth Group Incorporated, based in Eden Prairie, Minnesota, is a healthcare company providing a wide range of services. It operates through segments like Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, offering services such as care management, pharmacy services, and health benefits plans. Led by CEO Stephen J. Hemsley, UnitedHealth Group serves a diverse clientele across the United States and internationally, employing about 390,000 people.

Bottom Line

The insider buying activity by Kristen Gil and others at UnitedHealth Group adds to the interest in this major healthcare player. With a strong market position and consistent analyst support, UnitedHealth remains a stock to watch. As always, remember that insider transactions are disclosed after the fact and may not indicate future performance.